Evidence map›Paper›PMID 41830989›Full record

ReviewFolia microbiologica2026

Interactions of microbial biofilms with metal nanoparticles in the context of bioremediation.

Maria S Kuyukina, Elena A Bayandina, Irina B Ivshina

Abstract readReview
PubMed Publisher
In one paragraph

Review in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Maria S KuyukinaMicrobiology and Immunology Department, Perm State University, 15 Bukirev street, Perm, 614068, Russia. kuyukina@iegm.ru.
Elena A BayandinaMicrobiology and Immunology Department, Perm State University, 15 Bukirev street, Perm, 614068, Russia.
Irina B IvshinaMicrobiology and Immunology Department, Perm State University, 15 Bukirev street, Perm, 614068, Russia.

Funding

Ministry of Science and Higher Education of the Russian Federation FSNF-2025-0013, 124020500028-4 and 122031400671-1
6 · The paper itself

Abstract

Microbial biofilms are of growing interest in the field of bioremediation due to their stress resistance and high biodegradation activity. On the other hand, metal nanoparticles (MNPs) are increasingly being used as effective catalysts for the binding of heavy metals and the dehalogenation of persistent organic pollutants. The present review is aimed at the comprehensive analysis of beneficial biofilm interactions with MNPs in the context of bioremediation applications. Particular emphasis is placed on the concentration-dependent nature of these interactions, where low doses of MNPs stimulate the metabolic activity of biofilms, while high doses exert toxic effects. The proposed mechanisms of low-dose stimulatory effects of MNPs include: (i) enhanced cell adhesion, changes in the extracellular polymeric substance (EPS) composition and increased biosurfactant activity possibly regulated by a quorum sensing system, (ii) induction of moderate oxidative stress that activates metabolic processes, including antioxidant systems and catabolic pathways, (iii) improving electron transport in the biodegradation system by serving as electron donors or electron shuttles, (iv) direct enzymatic reduction of metal ions within the biofilm matrix, leading to the formation of biogenic MNPs and hydrogen, which are involved in the reductive decomposition of organic pollutants and the immobilization of toxic metals. Practical applications of hybrid nanobiosystems for the removal of various pollutants, as well as environmental risks and future prospects are discussed.

Indexed as

BiofilmsBioremediationMetal nanoparticlesNanobiosystems

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.